Prabhudas Lilladher Keeps Accumulate Rating on Kansai Nerolac, Target Price Rs 235

BROKERAGE-REPORTS
Whalesbook Logo
AuthorAarav Shah|Published at:
Prabhudas Lilladher Keeps Accumulate Rating on Kansai Nerolac, Target Price Rs 235

Brokerage firm Prabhudas Lilladher has retained its 'Accumulate' rating on Kansai Nerolac Paints, while adjusting the target price to Rs 235. The update follows the company's recent second-quarter financial results, which highlighted a mix of steady demand alongside pressure on profit margins.

Prabhudas Lilladher has maintained its 'Accumulate' rating on Kansai Nerolac Paints, even as it lowered the target price to Rs 235 per share from the previous Rs 259. This adjustment reflects a updated valuation model following the company's recent quarterly performance updates. The brokerage firm noted that while the company faces immediate headwinds, its market position in both industrial and decorative coatings provides a foundation for long-term growth.

Financial Performance and Margin Pressure

The update comes shortly after Kansai Nerolac Paints released its financial results for the second quarter of the 2027 fiscal year on November 4, 2026. While the company recorded revenue growth, the results revealed significant pressure on operating profit margins. This contraction has been a key area of focus for investors, as rising costs have impacted the company's profitability despite consistent demand in its core segments.

The brokerage anticipates that Kansai Nerolac will aim to sustain operating margins within a 13-14% range in the near term. Achieving this will likely depend on the company's ability to manage costs effectively, as volatility in the prices of raw materials—specifically crude oil derivatives—remains a major challenge. The company is also navigating a competitive landscape, particularly in the decorative paints segment, where heavy competition often limits the ability to pass on cost increases to consumers.

Strategic Focus and Market Outlook

Kansai Nerolac continues to focus on its long-term strategy, which includes expanding its distribution network and scaling its project-based business. The company is also in the process of structural consolidation, including the amalgamation of Nerofix Private Limited, which was recently approved by the National Company Law Tribunal (NCLT). These moves are intended to streamline operations and improve efficiency.

Looking ahead, investors may watch for signs of margin recovery and the company's ability to navigate potential cooling in discretionary consumer spending. Any sustained volatility in global supply chains or further escalation in raw material prices could continue to weigh on the company's bottom line. The balance between maintaining market share and protecting profit margins will remain a primary factor for the stock's future performance as the company moves into the second half of the fiscal year.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.